BY DANIEL FRANK CHRISTENSEN
-
ESET shines light on cyber criminal RedLine empire
ESET radiates light on cyber criminal RedLine realmRead More
-
Beyond VPNs: The future of secure remote connectivity
Beyond VPNs: The future of protected remote connectionRead More
-
What are the security risks of bring your own AI?
What are the safety dangers of bring your very own AI?Read More
-
Storage explained: Consumption models of storage procurement
Storage explained: Consumption models of storage procurementRead More
-
Novo’s new obesity drug is targeting the most dramatic weight loss yet
Novo Nordisk’s weight-loss franchise business might come to be the globe’s top-seller in 2024, yet competitors presses Novo to progress with CagriSema, a mix therapy th…
-
Ozempic sister drug cuts heart risk in large study
Novo Nordisk’s Rybelsus tablet decreases cardiovascular disease and stroke danger amongst diabetics, research study discovers, boosting the instance for wider usage.
-
Mpox death toll hits 1,100 in Africa with cases still rising
Mpox has actually declared 1,100 lives in Africa this year, driven by vaccination lacks and chock-full evacuee camps and jails, with the condition likewise creating loss of sight a…
-
Why this pharma boss isn’t chasing the obesity hype
Bloomberg interviews Merck CEO Belen Garijo, whose focus is on repositioning the corporate as a world chief in oncology and immunology – not pursuring the weight-loss market.
